Patents by Inventor Bryon NICHOLSON

Bryon NICHOLSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240050555
    Abstract: The present invention relates to immunogenic compositions comprising recombinantly constructed polypeptides useful for preparing vaccines, in particular for reducing one or more clinical signs caused by a rotavirus infection. More particular, the present invention is directed to an immunogenic composition containing (i) a fusion protein comprising in N- to C-terminal direction (A) an immunogenic fragment of a rotavirus VP8 protein and (B) an immunoglobulin Fc fragment such as, for example, an IgG Fc fragment, and (ii) an immunogenic substance, different from said fusion protein, wherein said immunogenic composition is usable in a method of reducing one or more clinical signs, mortality or fecal shedding caused by a rotavirus infection in swine.
    Type: Application
    Filed: April 4, 2023
    Publication date: February 15, 2024
    Inventors: Abby Rae PATTERSON, David Michael ANSTROM, Gregory Brian HAIWICK, Wesley Scott JOHNSON, Dianna M. Murphy JORDAN, Bryon NICHOLSON, Eric Martin VAUGHN, Justin WIDENER
  • Publication number: 20220160864
    Abstract: The present invention relates to recombinantly constructed polypeptides useful for preparing vaccines, in particular for reducing one or more clinical signs caused by an infection with at least one pathogen, such as clinical signs caused by a viral infection. More particular, the present invention is directed to a polypeptide comprising a Circoviridae capsid protein linked to a heterologous protein or fragment thereof, and to chimeric virus-like particles composed of such polypeptides. In one example, a fusion protein is provided which comprises PCV2 ORF2 protein linked to an immunogenic fragment of rotavirus VP8 protein, and which is usable for reducing one or more clinical signs, mortality or fecal shedding caused by a rotavirus infection in swine.
    Type: Application
    Filed: October 4, 2021
    Publication date: May 26, 2022
    Inventors: David ANSTROM, Abby Rae PATTERSON, Gregory Brian HAIWICK, Wesley Scott JOHNSON, Bryon NICHOLSON, Eric Martin VAUGHN
  • Publication number: 20220160866
    Abstract: The present invention relates to recombinantly constructed polypeptides useful for preparing vaccines, in particular for reducing one or more clinical signs caused by a rotavirus infection. More particular, the present invention is directed to a fusion protein comprising in N- to C-terminal direction (i) an immunogenic fragment of a rotavirus VP8 protein and (ii) an immunoglobulin Fc fragment such as, for example, an IgG Fc fragment, wherein said fusion protein is usable in a method of reducing one or more clinical signs, mortality or fecal shedding caused by a rotavirus infection in swine.
    Type: Application
    Filed: October 4, 2021
    Publication date: May 26, 2022
    Inventors: David ANSTROM, Abby Rae PATTERSON, Gregory Brian HAIWICK, Wesley Scott JOHNSON, Bryon NICHOLSON, Eric Martin VAUGHN